Please check your internet connection and try again.
# Tab%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520voihep
## Overview
Tab%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520voihep is a nucleoside analog used for the treatment of chronic hepatitis B virus (HBV) infection.
## Primary Indications
Chronic Hepatitis B infection.
## Adult Dosing
The recommended dose is 300 mg orally once daily.
## Pediatric Dosing
Established pediatric dosing is not available. Consult specialized literature or local protocols for potential use in pediatric patients.
## Dose Adjustments
No dose adjustment is required for patients with mild to moderate renal impairment. For severe renal impairment (CrCl < 30 mL/min), dose adjustments are necessary, and specific recommendations should be followed based on renal function. Dose adjustments for hepatic impairment are generally not required.
## Contraindications
Known hypersensitivity to Tab%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520voihep or any of its excipients.
## Adverse Effects
Common adverse effects include headache, dizziness, nausea, diarrhea, fatigue, and abdominal pain. Serious adverse effects may include lactic acidosis, severe hepatomegaly with steatosis, and potential for HBV resistance.
## Key Drug Interactions
No significant drug interactions have been widely reported with Tab%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520voihep. However, concurrent use with drugs known to cause lactic acidosis should be approached with caution.
## Monitoring
Liver function tests (ALT, AST, bilirubin), HBV DNA levels, and renal function should be monitored regularly. Patients should be assessed for signs and symptoms of lactic acidosis and severe hepatomegaly.
## Clinical Pearls
Discontinuation of Tab%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520voihep may lead to severe exacerbation of hepatitis B. If treatment is stopped, patients should be closely monitored for signs of hepatic decompensation.
***
*This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines before making treatment decisions.*
